Method and device for immunoassay using nucleotide conjugates

• US 9,207,246 B2
• Filed: 04/18/2013
• Issued: 12/08/2015
• Est. Priority Date: 12/31/2008
• Status: Active Grant

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Collier, G. Bruce, Miller, Cary James
• Primary Examiner(s): BROWN, MELANIE YU
• Application Number:
  US13/865,425
• Publication Number:
  US 20130230854A1
• Time in Patent Office: 964 Days
• US Class Current: 1/1
• CPC Class Codes: G01N 2458/10 Oligonucleotides as tagging agents for labelling antibodies
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: G01N 33/5306 Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
• CPC Class Codes: G01N 33/58 involving labelled substances G01N33/53 takes precedence
• CPC Class Codes: G01N 33/6887 from muscle, cartilage or connective tissue

Abstract

A composition of matter for use in an immunoassay devices and method comprising a signal antibody, e.g., FAB fragment, covalently linked to a first nucleotide; and one or more signal elements, e.g., signal enzymes such as ALP or fluorescent dyes, each covalently linked to a second nucleotide, wherein the first nucleotide has one or more repeated sequences, and the second nucleotide is bound to one of the one or more repeated sequences on said first nucleotide, and wherein the ratio of the signal antibody to the signal element is controlled by the number of repeated sequences.

Claims

1. A single-use cartridge for performing an immunoassay, comprising:

a sample entry port for receiving a blood sample suspected of containing a target analyte,

a conduit containing an electrode,

a region containing a wash fluid,

a waste chamber,

immobilized first antibody capable of binding to said target analyte,

second antibody disposed in a solubilizing agent disposed within said conduit and capable of binding to said target analyte, wherein the second antibody is attached to a first single stranded nucleotide, and

one or more signal elements each attached to a second single stranded nucleotide having complimentary base pairs to the first single stranded nucleotide;

wherein;

the wash fluid is capable of washing said blood sample from said electrode in said conduit into said waste chamber, and

a 3′

-end or 5′

-end of the a first single stranded nucleotide and the a second single stranded nucleotide is protected from endogenous exonuclease activity from said blood sample within the conduit by incorporating a protective chemical group.

2. The cartridge of claim 1, wherein the one or more signal elements comprise a non-enzymatic detection moiety that is selected from the group consisting of fluorescent, colorimetric, and radioactive elements.

3. The cartridge of claim 1, wherein the one or more signal elements comprise one or more signal enzymes, the cartridge further comprising:

a region containing an enzyme substrate,

wherein said enzyme substrate is capable of reacting with said one or more signal enzymes to generate a signal at said electrode proportionate to the amount of said target analyte in said blood sample.

4. The cartridge of claim 3, wherein the first antibody binds to a first epitope of the target analyte.

5. The cartridge of claim 3, wherein the second antibody binds to a second epitope of the target analyte.

6. The cartridge of claim 3, wherein the one or more signal enzymes are selected from the group consisting of alkaline phosphatase, glucose oxidase, lactate oxidase, urease, horseradish peroxidase, galactose oxidase, and beta-galactosidase.